Financial Update: Apyx Medical Corp Reports Q1 2025 Results

On May 8, 2025, Apyx Medical Corporation, a health care equipment and supply company based in Clearwater, United States, announced its financial results for the first quarter of 2025. The company, which specializes in electrosurgical products and technologies, reported a GAAP earnings per share (EPS) of -$0.10, surpassing expectations by $0.02. Additionally, Apyx Medical achieved a revenue of $9.43 million, exceeding forecasts by $0.04 million.

These results were highlighted in a report by Seeking Alpha, which noted the company’s performance against market expectations. Apyx Medical’s primary market is in Florida, where it serves customers with its range of electrosurgical pencils, accessories, desiccators, generators, and electrodes.

As of May 5, 2025, Apyx Medical’s stock was trading at $1.07 on the Nasdaq, with a market capitalization of $40.44 million. The company’s 52-week high was recorded at $1.99 on May 9, 2024, while the 52-week low stood at $0.7554 as of April 3, 2025. The price-to-earnings ratio was reported at -1.88, reflecting the company’s current financial performance.

In anticipation of the earnings report, Yahoo Finance provided a preview on May 7, 2025, outlining key areas of focus for investors. The report emphasized the importance of understanding the company’s revenue streams and operational efficiency in the context of its financial results.

Founded in 1987, Apyx Medical has been a player in the health care equipment and supplies sector, with a focus on innovation in electrosurgical technologies. For more detailed information on their offerings and initiatives, stakeholders can visit the company’s website at www.apyxmedical.com .

These financial results and insights provide a comprehensive view of Apyx Medical’s current standing and future prospects in the health care sector.